Quick Summary
- B12 alone covers the SAMe/myelin pathway — sufficient if demyelination is the primary concern.
- B-Complex adds B1 (transketolase), B6 (AADC/GAD neurotransmitters), and B9 (folate trap resolution).
- Multi-pathway symptoms (tingling + burning + fatigue) suggest B-Complex over B12 alone.
- Single-pathway symptoms (numbness only) may respond to targeted B12 supplementation.
Quick Answer: One Pathway vs. Three
| Pathway | Symptom Pattern | B12 Alone | B-Complex (B1+B6+B12) |
|---|---|---|---|
| Demyelination (SAMe/myelin) | Bilateral numbness, vibration loss, unsteady gait | ✓ Covers via methionine synthase → SAMe | ✓ B12 component covers this |
| Axonal energy (transketolase) | Burning pain, temperature insensitivity | ✗ B12 does not activate transketolase | ✓ B1 activates transketolase → PPP → ATP |
| Neurotransmitter (AADC/GAD) | Dysesthesia, altered pain perception | ✗ B12 is not an AADC/GAD cofactor | ✓ B6 cofactors AADC → serotonin/dopamine, GAD → GABA |
If only one pathway is involved (pure demyelination), B12 alone addresses the bottleneck. If multiple pathways are involved, B-Complex covers non-overlapping mechanisms
When B12 Alone Is the Right Choice
B12 is the sole cofactor for methionine synthase — the enzyme that converts homocysteine to methionine, which is then adenylated to SAMe. SAMe methylates phosphatidylethanolamine to phosphatidylcholine in Schwann cells, maintaining myelin integrity
B12 alone is the right choice when:
- Blood tests confirm isolated B12 deficiency: serum B12 <200 pg/mL, MMA >0.4 μmol/L, homocysteine >15 μmol/L
- Symptoms match large-fibre demyelination: bilateral glove-and-stocking numbness, impaired vibration sense, positive Romberg sign
- No burning pain or temperature-sense loss (which would implicate the B1/transketolase pathway)
- No dysesthesia or altered pain perception (which would implicate the B6/AADC-GAD pathway)
- The clinical question is specifically about correcting a confirmed B12 deficiency
When B-Complex Becomes Necessary
Nerve damage rarely involves a single pathway. When symptoms include both numbness AND burning, or when diabetes is part of the picture, multiple biochemical failures are likely occurring simultaneously:
B1 (Thiamine/Benfotiamine) — Axonal Energy
Thiamine diphosphate activates transketolase — the rate-limiting enzyme in the pentose phosphate pathway. This produces ribose-5-phosphate for ATP synthesis and NADPH for glutathione regeneration. When transketolase activity drops, small-fibre axons lose their energy supply. Burning pain with preserved touch but impaired temperature sense is the hallmark
B6 (P5P) — Neurotransmitter Balance
P5P is the obligate cofactor for AADC (aromatic L-amino acid decarboxylase), which converts 5-HTP → serotonin and L-DOPA → dopamine. It also cofactors GAD (glutamic acid decarboxylase), converting glutamate → GABA. When P5P is deficient, the GABA/glutamate balance shifts toward excitation, producing heightened nerve sensitivity and dysesthesia
B12 (Methylcobalamin) — Myelin Maintenance
The SAMe → phosphatidylcholine → myelin pathway described above. In a B-Complex, B12 handles the same pathway it would handle alone — but now B1 and B6 cover the two additional pathways B12 cannot reach
The Key Principle: Non-Overlapping Pathways
B12 cannot activate transketolase. B1 cannot feed methionine synthase. B6 cannot produce phosphatidylcholine. These are biochemically independent enzymes with different cofactor requirements
Saturating one pathway does not compensate for deficiency in another. This is why the B12-vs-B-Complex question is not about "more is better" — it is about matching the number of failing pathways to the number of cofactors provided